Michael S. Cuffe, EVP and Chief Clinical Officer at HCA Healthcare, Inc. (HCA), sold 30,438 shares at $385.42 ($11.7M) on 2024-09-12, disclosed to the SEC on 2024-09-12.
Scheduled sale ($11.7M) by EVP and Chief Clinical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $386.43 | 13,722 | $5.3M | 45.1% |
| 2 | $385.42 | 8,358 | $3.2M | 27.4% |
| 3 | $385.42 | 8,358 | $3.2M | 27.4% |
| Total | $385.88 avg | 30,438 | $11.7M | 100% |
| Filing → |
| HCA | SELL | 2024-05-13 | $4.0M | — | Filing → |
| HCA | SELL | 2024-05-08 | $494K | — | Filing → |
| HCA | SELL | 2024-02-02 | $2.0M | — | Filing → |